p53 in nonneoplastic central nervous system lesions: An immunohistochemical and genetic sequencing study

Kurtkaya-Yapicier O., Scheithauer B., Hebrink D., James C.

NEUROSURGERY, cilt.51, sa.5, ss.1246-1254, 2002 (SCI İndekslerine Giren Dergi) identifier identifier identifier


OBJECTIVE: Immunostaining for p53 commonly is considered a marker of neoplasia. Previous studies of nonneoplastic processes have yielded conflicting results.